Definitive Healthcare (NASDAQ:DH) Shares Down 5.6% - Here's Why

Key Points

• Definitive Healthcare's stock dropped by 5.6% to $3.65, with trading volume significantly lower than average, indicating reduced investor activity.
• Analysts have mixed ratings for the stock, with target prices ranging from $3.00 to $6.00 and an average rating of "Hold" based on recent performance and forecasts.
• The company reported a revenue of $59.19 million for its last quarter, surpassing analyst expectations, although it showed a decline in net margin compared to the same quarter last year.

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) shares were down 5.6% on Monday . The company traded as low as $3.67 and last traded at $3.65. Approximately 373,065 shares traded hands during trading, a decline of 56% from the average daily volume of 840,128 shares. The stock had previously closed at $3.86.

Analyst Upgrades and Downgrades

DH has been the subject of a number of research reports. The Goldman Sachs Group lifted their price objective on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a report on Monday, May 12th. Stifel Nicolaus boosted their price objective on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Wall Street Zen raised shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, June 21st. Robert W. Baird set a $4.00 price target on Definitive Healthcare in a research report on Friday, August 8th. Finally, BTIG Research cut Definitive Healthcare from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $4.73.

Definitive Healthcare Stock Up 1.8%

The company has a quick ratio of 1.75, a current ratio of 1.65 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $553.95 million, a P/E ratio of -1.46, a PEG ratio of 6.40 and a beta of 1.64. The business has a 50-day simple moving average of $3.91 and a two-hundred day simple moving average of $3.59.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. raised its stake in shares of Definitive Healthcare by 564.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company's stock worth $25,191,000 after purchasing an additional 7,404,363 shares in the last quarter. Arrowstreet Capital Limited Partnership bought a new position in shares of Definitive Healthcare in the second quarter worth $4,247,000. Whetstone Capital Advisors LLC bought a new stake in Definitive Healthcare during the first quarter worth $2,512,000. Irenic Capital Management LP lifted its position in shares of Definitive Healthcare by 9.2% during the 4th quarter. Irenic Capital Management LP now owns 7,003,194 shares of the company's stock worth $28,783,000 after buying an additional 590,009 shares during the last quarter. Finally, Susquehanna Fundamental Investments LLC acquired a new position in Definitive Healthcare during the fourth quarter worth about $1,181,000. Institutional investors and hedge funds own 98.67% of the company's stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.